Although increased plasma concentrations of loratadine and its active metabolite desloratadine have been reported when the drug was concomitantly administered with therapeutic dosages of ketoconazole, erythromycin, clarithromycin, or cimetidine in controlled clinical pharmacology studies in healthy individuals, no clinically important changes in electrocardiogram or laboratory evaluations, vital signs, or adverse effects were reported.